Hemophagocytic lymphohistiocytosis

May 28, 2020

Cincinnati Children's HLH Research Points to Treatment for COVID-19 Cytokine Storms

Dec 05, 2019

Data to be Highlighted at the American Society of Hematology 2019 Annual Meeting

Aug 28, 2019

CytoSorbents Highlights Recent Published Studies on CytoSorb

Jun 18, 2019

New Data Demonstrates Impact of Emapalumab in Patients With Macrophage Activation Syndrome (MAS)

Mar 25, 2019

Sobi and Novimmune Selected as Honourees for 2019 National Organization for Rare Disorders (NORD) Rare Impact Award in Industry Innovation for Gamifant® (emapalumab)

Dec 03, 2018

Data Presented at ASH Support Emapalumab as an Innovative, Targeted Therapeutic Option for Primary HLH

Nov 22, 2018

Late-breaking Abstract at ASH Supports Evidence on Transformative First-ever Treatment in Primary HLH

Nov 20, 2018

FDA approves first treatment specifically for patients with rare and life-threatening type of immune disease

Aug 23, 2018

Sobi(TM) Completes Acquisition of the Global Rights for Emapalumab From Novimmune